$BBl;3!!Gn;V!JEl5~G@9)Bg3X!K!&A0ED!!8w<#!JJ<8K8)N)Bg3X!K(B |
$B:`NA!&3&LLIt2q(B/$B>=@O5;=QJ,2J2q$G$O!"3K2=@.D9$N>=@O8=>]$NM}O@E*$JE83+$d!"?7$?$J7k>=@-J*=@O$K4X$9$k?7$?$J5;=Q$O!"0eLt!"?)IJ!"?7AG:`3+H/!"4D6-$J$II}9-$$J,Ln$KE83+$5$l$F$$$k!#K\%7%s%]%8%&%`$G$O>=@O5;=Q$N2#CGE*$J>pJs8r49$d5DO@$N>l$rDs6!$9$k!#$J$*!$3hH/$JF$O@$r4|BT$9$Y$/!$K\%7%s%]%8%&%`$G$O!VH/I=#1#2J,!\F$O@#8J,!W$N;~4VG[J,$H$9$k!#(B
$B:G=*99?7F|;~!'(B2016-01-20 13:09:01
$B$3$NJ,N`$G$h$/;H$o$l(B $B$F$$$k%-!<%o!<%I(B | $B%-!<%o!<%I(B | $B | |
---|---|---|---|
crystallization | 7$B7o(B | ||
Nucleation | 3$B7o(B | ||
Cyclodextrin | 2$B7o(B | ||
reaction crystallization | 2$B7o(B | ||
melt crystallization | 1$B7o(B |
$B | $B9V1iBjL\!?H/I=$B%-!<%o!<%I(B | $BH/I=7A<0(B | |
---|---|---|---|
19 | ASP3026$B$N7k>=B?7A@)8f@oN,$H%$%s%i%$%s%i%^%sJ,8wK!$rMQ$$$?MO1U9=B$%b%K%?%j%s%0(B | Polymorph Raman | O |
22 | $B?e;@2=%9%H%m%s%A%&%`(B8$B?e1v7k>=$rE:2C$7$?1v2=%+%k%7%&%`(B6$B?e1vM;1U$N2aNd5Q29EY$K5Z$\$9 | Nucleation Melt Heat Storage | O |
116 | $B%7%/%m%G%-%9%H%j%s7O6bB0M-5!9=B$BN$X$NK'9aB2%+%k%\%s;@$N5[Ce(B | Adsorption Carboxylic acid Cyclodextrin | O |
133 | $BH?1~>=@OK!$K$h$kC:;@1vHy7k>=$NIJ | $BH?1~>=@O(B $BC:;@1vHyN3;R(B $BIJ | O |
171 | $B;iKC;@$NM;1U>=@O$K$*$1$kMO | melt crystallization effective distribution coefficient solute distribution theory | O |
172 | $B9b05NO2<$G$NL5EE2r%K%C%1%k!>%j%s$a$C$-$K4X$9$k | electroless plating high pressure hydrogen | O |
176 | $B%*%$%j%s%0%"%&%H$r7PM3$9$k7k>=2=8=>]$NB?@.J,Aj?^$rMQ$$$?2r@O(B | Crystallization Oiling-out phenomena Phase diagram | O |
178 | $B0[Aj3&LL$r>=@O>l$H$7$?7k>=N3;R72$N@.D98=>]$N4Q;!$H$=$NI>2A(B | Crystallization Templated crystallization Different Phase Interface | O |
433 | $B%I%i%`%U%l!<%+$rMQ$$$?6&>=E`7k>=@OK!$K$h$k(B(NH4)2SO4-Na2SO4-H2O$B7O$+$i$NG;=LN20B1U2s<}$NJ,N%FC@-$=$NB>$K$D$$$F(B | Drum flaker Eutectic point freezing concentration | O |
512 | $B@EEEE*Aj8_:nMQ$r6nF0NO$H$7$?%9%H%l%W%H%"%S%8%s$N7k>=2=(B | Electrostatic interaction Crystallization Streptavidin | O |
538 | Cr($B-7(B)$BB8:_2<$G$NN2;@%+%j%&%`7k>=$NMO2r$K$*$1$k3F7k>=LL$NI=LL2r@O(B | Dissolution Behavior Additives Energy Dispersive X-ray Spectrometry | O |
558 | $B5U?;F)Kl$K$h$kMO | Reverse Osmosis Crystallization Concentration Polarization | O |
582 | $B%*%$%k2=$r2p$7$?%0%k%?%A%*%s%J%H%j%&%`7k>=$N>=@O(B | crystallization solvate amorphous | O |
597 | $B%7%_%e%l!<%7%g%s$K$h$kM-5!J*7k>=$N3K2=!&@.D9B.EY%Q%i%a!<%?;;=P(B | nucleation rate growth rate simulation | O |
675 | $B;0;@2=%b%j%V%G%s?eOBJ*E:2C$K$h$k(BZMH$B7k>=$NJILLIUCeM^@)(B | Nuclear fuel reprocessing Zirconium molybdate hydrate Nucleation | O |
712 | $B | Reaction Crystallization Size Control Pt Particle | O |
781 | $B%(%T%,%m%+%F%-%s%,%l!<%H$N%7%/%m%G%-%9%H%j%sJq@\2=9gJ*$N7k>=@.D9B.EY$N2r@O(B | Clathrate Crystallization Cyclodextrin | O |
786 | $B7Z>F(Bdolomite$B7|By1U$NC:;@2=H?1~$K$h$k(BMg$BC:;@1v$N>=@O$HJ,N%(B | dolomite carbonation magnesium carbonate | O |
813 | $BDKIw$K$*$1$kG";@@O=P$KM?$($k29EY$N1F6A(B | crystallization uric acid gout | O |
869 | N2$B%U%!%$%s%P%V%k$HIOMOG^$NJ;MQ$K$h$k%0%j%7%s$N>=@O8=>](B -$BIOMOG^$N | glycine antisolvent crystallization fine-bubbles | O |
933 | $B%"%_%m%$%I@-%?%s%Q%/ | Amyloid Nucleation Bio-interface | O |
947 | $B4T85>=@O$K$*$1$k(BpH$B$K$h$k(BAu$BN3;R$NN37B@)8f$*$h$SN3;R@.D95!9=$N2rL@(B | reaction crystallization pH sub-micron Au particle | O |